Multilabel SegSRGAN-A framework for parcellation and morphometry of preterm brain in MRI.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 23 04 2024
accepted: 14 10 2024
medline: 2 11 2024
pubmed: 2 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Magnetic resonance imaging (MRI) is a powerful tool for observing and assessing the properties of brain tissue and structures. In particular, in the context of neonatal care, MR images can be used to analyze neurodevelopmental problems that may arise in premature newborns. However, the intrinsic properties of newborn MR images, combined with the high variability of MR acquisition in a clinical setting, result in complex and heterogeneous images. Segmentation methods dedicated to the processing of clinical data are essential for obtaining relevant biomarkers. In this context, the design of quality control protocols for the associated segmentation is a cornerstone for guaranteeing the accuracy and usefulness of these inferred biomarkers. In recent work, we have proposed a new method, SegSRGAN, designed for super-resolution reconstruction and segmentation of specific brain structures. In this article, we first propose an extension of SegSRGAN from binary segmentation to multi-label segmentation, leading then to a partitioning of an MR image into several labels, each corresponding to a specific brain tissue/area. Secondly, we propose a segmentation quality control protocol designed to assess the performance of the proposed method with regard to this specific parcellation task in neonatal MR imaging. In particular, we combine scores derived from expert analysis, morphometric measurements and topological properties of the structures studied. This segmentation quality control can enable clinicians to select reliable segmentations for clinical analysis, starting with correlations between perinatal risk factors, regional volumes and specific dimensions of cognitive development. Based on this protocol, we are investigating the strengths and weaknesses of SegSRGAN and its potential suitability for clinical research in the context of morphometric analysis of brain structure in preterm infants, and to potentially design new biomarkers of neurodevelopment. The proposed study focuses on MR images from the EPIRMEX dataset, collected as part of a national cohort study. In particular, this work represents a first step towards the design of 3-dimensional neonatal brain morphometry based on segmentation. The (free and open-source) code of multilabel SegSRGAN is publicly available at the following URL: https://doi.org/10.5281/zenodo.12659424.

Identifiants

pubmed: 39485735
doi: 10.1371/journal.pone.0312822
pii: PONE-D-24-14966
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0312822

Informations de copyright

Copyright: © 2024 Dollé et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Guillaume Dollé (G)

CNRS, LMR, UMR 9008, Université de Reims Champagne Ardenne, Reims, France.

Gauthier Loron (G)

CRESTIC, Université de Reims Champagne Ardenne, Reims, France.
Service de Médecine Néonatale et Réanimation Pédiatrique, CHU de Reims, Reims, France.

Margaux Alloux (M)

Service de Médecine Néonatale et Réanimation Pédiatrique, CHU de Reims, Reims, France.
Unité d'aide Méthodologique - Pôle Recherche, CHU de Reims, Reims, France.

Vivien Kraus (V)

CRESTIC, Université de Reims Champagne Ardenne, Reims, France.

Quentin Delannoy (Q)

CRESTIC, Université de Reims Champagne Ardenne, Reims, France.

Jonathan Beck (J)

Service de Médecine Néonatale et Réanimation Pédiatrique, CHU de Reims, Reims, France.

Nathalie Bednarek (N)

CRESTIC, Université de Reims Champagne Ardenne, Reims, France.
Service de Médecine Néonatale et Réanimation Pédiatrique, CHU de Reims, Reims, France.

François Rousseau (F)

IMT Atlantique, LaTIM INSERM U1101, Brest, France.

Nicolas Passat (N)

CRESTIC, Université de Reims Champagne Ardenne, Reims, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH